1 / 5
文档名称:

2014年职称英语考试 综合类B级C级 完形填空与阅读理解 字典版 重点预测标注版 正反打印.doc

格式:doc   页数:5
下载后只包含 1 个 DOC 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

2014年职称英语考试 综合类B级C级 完形填空与阅读理解 字典版 重点预测标注版 正反打印.doc

上传人:wanlidashan 2014/2/11 文件大小:0 KB

下载得到文件列表

2014年职称英语考试 综合类B级C级 完形填空与阅读理解 字典版 重点预测标注版 正反打印.doc

文档介绍

文档介绍:6 Once-daily Pill Could Simplify HIV Treatment
Bristol-Myers Myers Squibb and Gilead Sciences bined many HIV drugs into a single pill Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and HIV/AIDS,2 for example, are all treated binations of drugs. But that can mean a lot of pills to take. It would be simpler if bined all the medicines into a single pill, taken just once a day.
Now, panies say they have done that for people just starting treatment for HIV, the virus that causes AIDS. panies are Bristol-Myers Squibb and Gilead Sciences. They have developed a single pill bines three drugs currently on the Bristol-Myers Squibb sells one of them under the name of bined the others, Emtriva and Viread, into a single pill in two thousand four.
Combining drugs involves more than technical issues. It also involves issues petition if the drugs are made by panies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of HIV
In January the New England Journal of Medicine5 published a study of the new pill. pared its effectiveness to6 that of the widely bination of Sustiva bivir. Combivir contains two drugs, AZT7 and The researchers say that after one year of treatment, the new pill suppressed HIV levels in more patients and with fewer side Gilea